Clinical Trial Update: Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3 [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating low-dose peginterferon in combination with ribavirin to treat chronic hepatitis C in patients infected with HCV genotypes 2 or 3; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2011-06-27